1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA DCAKD CTRPv2 pan-cancer AAC -0.092 0.01
mRNA RPS6KL1 CTRPv2 pan-cancer AAC 0.096 0.01
mRNA FAM170B CTRPv2 pan-cancer AAC -0.089 0.01
mRNA ZNHIT6 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA MRPS15 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA PRUNE1 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA RGS14 CTRPv2 pan-cancer AAC 0.098 0.01
mRNA ROPN1B CTRPv2 pan-cancer AAC 0.1 0.01
mRNA ASF1B CTRPv2 pan-cancer AAC -0.093 0.01
mRNA ZRSR1 CTRPv2 pan-cancer AAC -0.09 0.01
Download CSV